Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SARS-CoV-2 convalescent plasma
BIOLOGICAL
5 trials
Sponsors
Johns Hopkins University
, Joakim Dillner
, University Hospital, Geneva
Conditions
COVID-19
Covid19
Immuno-Deficiency
Old Age; Debility
SARS-CoV 2
Phase 1
Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study
Completed
NCT04384497
Joakim Dillner
COVID-19
Start: 2020-05-07
End: 2020-12-01
Updated: 2021-12-03
Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19)
Completed
NCT04390178
Joakim Dillner
COVID-19
Start: 2020-04-10
End: 2020-12-31
Updated: 2021-12-16
Phase 2
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
Completed
NCT04373460
Johns Hopkins University
SARS-CoV 2
Start: 2020-06-03
End: 2022-12-14
Updated: 2023-06-02
Convalescent Plasma for Treatment of COVID-19
Completed
NCT04649879
Joakim Dillner
Covid19
Start: 2020-12-03
End: 2022-01-26
Updated: 2022-02-09
Phase 3
Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19
NCT04836260
University Hospital, Geneva
Covid19, Immuno-Deficiency, Old Age; Debility
Start: 2021-04-08
End: 2021-12-31
Target: 100
Updated: 2021-04-08
Related Papers
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial
JCI Insight
2024-03-14
11 citations
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial
The Journal of Infectious Diseases
2023-01-31
2 citations
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
New England Journal of Medicine
2022-03-30
264 citations
Pharmacokinetics of high-titer anti–SARS-CoV-2 human convalescent plasma in high-risk children
JCI Insight
2021-12-02
24 citations
Convalescent plasma for treatment of COVID-19: study protocol for an open randomised controlled trial in Sweden
BMJ Open
2021-12-01
2 citations
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults.
2021-03-20
13 citations